Literature DB >> 31040011

Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.

Sarahmona M Przybyla1, Kathleen Parks2, Jacob Bleasdale3, Joshua Sawyer4, Diane Morse5.   

Abstract

INTRODUCTION: The purpose of this study was to assess pharmacy students' awareness, knowledge, and perceptions towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), confidence and intentions to counsel patients on PrEP, and preferred PrEP training.
METHODS: A web-based cross-sectional survey was conducted with pharmacy students. Descriptive statistics and multivariate logistic regressions were performed.
RESULTS: Ninety-one percent of participants were aware of PrEP and 61% were familiar with PrEP prescription guidelines. In multivariate analysis, greater PrEP knowledge, attitudes towards PrEP, and familiarity with prescribing guidelines were significantly associated with confidence in PrEP counseling (p < 0.01 for all). Males had significantly higher odds of reporting confidence in PrEP counseling relative to their female counterparts (p < 0.01). Relative to fourth year students, second year students were less likely to report confidence in PrEP counseling (p < 0.01). Participants who were familiar with prescribing guidelines had significantly higher odds of PrEP counseling intentions (p < 0.05). Preferred educational topics regarding PrEP included training on side effects and adherence monitoring (65% and 51%, respectively). The most preferred modalities for receiving PrEP education were online education (47%), educational seminars in required courses (43%), and self-study modules (39%).
CONCLUSIONS: Given the key role played by pharmacists in patient engagement, they may be presented with opportunities to provide PrEP counseling and education. The development of educational modules for pharmacy students in an effort to increase PrEP uptake should consider addressing gaps in knowledge and preferred training modalities.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; Pharmacy students; Pre-exposure prophylaxis; Prevention

Year:  2019        PMID: 31040011      PMCID: PMC6800069          DOI: 10.1016/j.cptl.2019.01.011

Source DB:  PubMed          Journal:  Curr Pharm Teach Learn        ISSN: 1877-1297


  34 in total

Review 1.  Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.

Authors:  Kellie Freeborn; Carmen J Portillo
Journal:  J Clin Nurs       Date:  2018-09       Impact factor: 3.036

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.

Authors:  Deborah Yoong; Mark Naccarato; Malika Sharma; James Wilton; Heather Senn; Darrell Hs Tan
Journal:  Int J STD AIDS       Date:  2015-05-29       Impact factor: 1.359

4.  Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.

Authors:  Kristy M Shaeer; Elizabeth M Sherman; Sami Shafiq; Patrick Hardigan
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Nov-Dec

5.  PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.

Authors:  Andrew E Petroll; Jennifer L Walsh; Jill L Owczarzak; Timothy L McAuliffe; Laura M Bogart; Jeffrey A Kelly
Journal:  AIDS Behav       Date:  2017-05

6.  Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.

Authors:  Elizabeth J Unni; Nadia Lian; William Kuykendall
Journal:  J Am Pharm Assoc (2003)       Date:  2016 Sep-Oct

7.  Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians.

Authors:  Oliver Bacon; Rafael Gonzalez; Erin Andrew; Michael B Potter; James R Iñiguez; Stephanie E Cohen; Albert Y Liu; Jonathan D Fuchs
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

8.  HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic.

Authors:  J Carlo Hojilla; David Vlahov; Pierre-Cedric Crouch; Carol Dawson-Rose; Kellie Freeborn; Adam Carrico
Journal:  AIDS Behav       Date:  2018-04

9.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

10.  Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation.

Authors:  Ian Ross; Carlos Mejia; Johanna Melendez; Philip A Chan; Amy C Nunn; William Powderly; Katherine Goodenberger; Jingxia Liu; Kenneth H Mayer; Rupa R Patel
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

View more
  8 in total

1.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

2.  Where Do Health Professions Students Learn About Pre-exposure Prophylaxis (PrEP) for HIV Prevention?

Authors:  Samuel R Bunting; Sarah K Calabrese; Sarah S Garber; Timothy D Ritchie; Tamzin J Batteson
Journal:  Med Sci Educ       Date:  2021-03-15

3.  Willingness to Prescribe PrEP to Bisexual Men Depends on Genders of Their Past Partners: A Study of Medical Students in the USA.

Authors:  Brian A Feinstein; Cindy J Chang; Samuel R Bunting; Jesse Bahrke; Aniruddha Hazra; Sarah S Garber
Journal:  Arch Sex Behav       Date:  2022-06-10

4.  Interest In and Uptake of HIV Pre-Exposure Prophylaxis (PrEP): A Cross-Sectional Study of High-Risk Patients in Western Canada.

Authors:  Stanley Enebeli; Udoka Okpalauwaekwe; Prosanta K Mondal; Johnmark Opondo; Anne Leis
Journal:  Cureus       Date:  2022-04-19

5.  Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

Authors:  Samuel R Bunting; Sarah S Garber; Robert H Goldstein; Timothy D Ritchie; Tamzin J Batteson; Timothy J Keyes
Journal:  J Gen Intern Med       Date:  2020-02-20       Impact factor: 5.128

6.  Knowledge of HIV and HIV pre-exposure prophylaxis among medical and pharmacy students: A national, multi-site, cross-sectional study.

Authors:  Samuel R Bunting; Brian A Feinstein; Aniruddha Hazra; Neeral K Sheth; Sarah S Garber
Journal:  Prev Med Rep       Date:  2021-10-07

Review 7.  Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.

Authors:  Alice Zhao; Derek T Dangerfield; Amy Nunn; Rupa Patel; Jason E Farley; Chinenye C Ugoji; Lorraine T Dean
Journal:  AIDS Behav       Date:  2021-10-20

8.  Knowledge, Attitudes, and Intentions towards HIV Pre-Exposure Prophylaxis among Nursing Students in Spain.

Authors:  Guillermo López-Díaz; Almudena Rodríguez-Fernández; Eva María Domínguez-Martís; Diego Gabriel Mosteiro-Miguéns; David López-Ares; Silvia Novío
Journal:  Int J Environ Res Public Health       Date:  2020-09-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.